Medicine & Life Sciences
(methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine
62%
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
39%
Agraphia
13%
Alzheimer Disease
100%
Amyloid
39%
Amyotrophic Lateral Sclerosis
12%
Apathy
15%
Atrophy
12%
Autosomal recessive Spastic paraplegia 11
19%
Biomarkers
22%
Brain
49%
Carbon-11
14%
Chromosomes, Human, Pair 15
12%
Clinical Trials
21%
Cognitive Dysfunction
26%
Corpus Callosum
15%
Dementia
42%
Disorders of Excessive Somnolence
12%
Ear
17%
Essential Tremor
12%
Flumazenil
12%
Frontotemporal Dementia
74%
Frontotemporal Lobar Degeneration
50%
Hereditary Spastic Paraplegia
13%
Inflammation
19%
Intermediate Filaments
19%
Language
15%
levodopa drug combination carbidopa
13%
Light
12%
Linguistics
11%
Lynx
31%
Magnetic Resonance Imaging
28%
Memory
12%
Mobile Applications
24%
Muscarinic M4 Receptors
15%
Mutation
15%
Neurodegenerative Diseases
12%
Neuroimaging
36%
Parkinson Disease
17%
Positron-Emission Tomography
37%
Primary Progressive Aphasia
22%
Primary Progressive Nonfluent Aphasia
14%
Proteins
12%
Psycholinguistics
13%
Psychology Recognition
12%
Regulatory T-Lymphocytes
17%
Smartphone
32%
Spastic Paraparesis
13%
Specific Language Disorder
12%
Vascular Dementia
18%